Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

United States Depyrogenated Sterile Empty Vials (2 ml, 5 ml, 10 ml, 20 ml) Market Size, Share & Trends Analysis Report, 2018-2025 - ResearchAndMarkets.com

Research and Markets
Posted on: 16 Nov 18

The "U.S. Depyrogenated Sterile Empty Vials Market Size, Share & Trends Analysis Report By Product (2 ml, 5 ml, 10 ml, 20 ml), By End Use (Clinical Labs, Compounding Pharmacies), And Segment Forecasts, 2018 - 2025" report has been added to ResearchAndMarkets.com's offering.

The U.S. depyrogenated sterile empty vials market size is likely to reach USD 3.5 billion by 2025, progressing at a CAGR of 5.2% during the forecast period.

Technological advancements in pharmaceutical packaging process, growing funding by government organizations, and flourishing biologics market in the U.S. are some of the key trends escalating market growth. Stringent regulations laid by the government for parenteral are also poised to augment the market.

Rising number of clinical labs in the country is resulting in an increased number of medical and diagnostic tests. This, in turn, is fueling the demand for depyrogenated sterile empty vials. Increasing number of compounding laboratories and research institutes in the U.S. is boosting the demand for these vials in the market. Moreover, continual growth in the pharmaceutical and biotechnology industry is further projected to drive the market.

Increasing number of collaborations in order to achieve innovative packaging technology is also providing an upthrust to the market. Rising incidence of infectious & non-infectious diseases and growing number of clinical studies are translating into a greater demand for these vials. Besides this, the government is backing the promotion of pharmaceutical, medical, and biotechnological researches, which is anticipated to work in favor of the market.

Further key findings from the report suggest:

  • More than 20 ml depyrogenated sterile empty vials emerged as the largest segment in terms of revenue in 2017 owing to rising incidence of infectious & non-infectious diseases and increasing investments in the biopharmaceutical sector
  • Others, which include pharmaceutical manufacturers and academic & research institutes, formed the most prominent end-use segment in 2017. The growth of the segment can be attributed to expanding base of medical & biotech research institutes and upswing in pharmaceutical manufacturing
  • Thermo Fisher Scientific, Inc.; Gerresheimer AG; SCHOTT AG; and DWK Life Sciences are the major players operating in the market. This market is considerably fragmented and market entry barrier is high.

Key Topics Covered:

Chapter 1 Research Methodology

Chapter 2 Executive Summary

Chapter 3 U.S. Depyrogenated Sterile Empty Vials Market Variables, Trends & Scope

3.1 Market Segmentation & Scope

3.2 Market Driver Analysis

3.2.1 Technological advancements

3.2.2 Growth in pharmaceutical sector

3.2.3 Growing compounding pharmacies and clinical laboratories in the U.S.

3.3 Market Restraint Analysis

3.3.1 Growing demand for other parenteral packaging alternatives

3.4 Penetration & Growth Prospect Mapping

3.5 End Use Product Adoption/ Product Penetration Analysis

3.6 Pricing Analysis by Brand

3.7 U.S. Depyrogenated Sterile Empty Vials Market - SWOT Analysis, By Factor (political & legal, economic and technological)

3.8 Industry Analysis - Porter's

Chapter 4 U.S. Depyrogenated Sterile Empty Vials Market: Product Estimates & Trend Analysis

4.1 U.S. Depyrogenated Sterile Empty Vials Market: Product Movement Analysis, 2017 & 2025

4.2 2mL Vials

4.3 5mL Vials

4.4 10mL Vials

4.5 20 ml Vials

4.6 More than 20 ml Vials

Chapter 5 U.S. Depyrogenated Sterile Empty Vials Market: End use Estimates & Trend Analysis

5.1 U.S. Depyrogenated Sterile Empty Vials Market: End use Movement Analysis, 2017 & 2025

5.2 Clinical Laboratories

5.3 Compounding Pharmacies

5.4 Other End uses

Chapter 6 Company Profiles

  • Thermo Fisher Scientific, Inc.
  • VWR International, LLC
  • Stevanato Group
  • SiO2 Medical Products, Inc.
  • DWK Life Sciences
  • Merck KGaA
  • Gerresheimer AG
  • Corning, Inc.
  • SCHOTT Corporation

For more information about this report visit https://www.researchandmarkets.com/research/rhjnl7/united_states?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20181116005335/en/

Business Wire
www.businesswire.com

Last updated on: 16/11/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.